Wall Street Associates’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Wall Street Associates’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-11,350	Closed	-$1.28M	–	312
2015 Q4	$1.28M	Sell	11,350 -700	-6%	-$77.1K	0.36%	97
2015 Q3	$1.42M	Sell	12,050 -17,482	-59%	-$2.28M	0.27%	109
2015 Q2	$2.29M	Sell	29,532 -30,298	-51%	-$1.99M	0.22%	119
2015 Q1	$3.46M	Sell	59,830 -11,012	-16%	-$468K	0.33%	101
2014 Q4	$2.29M	Buy	+70,842	New	+$2.13M	0.22%	134

Other funds holding ANAC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Wall Street Associates's ANAC Position: Q1 2016 in Review

Wall Street Associates sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q1 2016, closing a stake of 11,350 shares — an estimated $1.28M sold.

Wall Street Associates first reported a position in ANAC in Q4 2014 and held it in 5 quarters. The position peaked at $3.46M in Q1 2015. 199 funds tracked by Wall St. Rank hold ANAC as of Q1 2016.

Wall Street Associates reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q1 2016 after selling out during the quarter.
Wall Street Associates sold 11,350 ANACOR PHARMACEUTICALS INC COM shares in Q1 2016, an estimated $1.28M.
Wall Street Associates first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2014 and held it in 5 quarters.
Wall Street Associates's ANACOR PHARMACEUTICALS INC COM position peaked at $3.46M in Q1 2015.
199 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q1 2016.

Based on Wall Street Associates's 13F filing for Q1 2016, filed 13 May 2016.